BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3910314)

  • 1. Suboptimal C3b/C3bi deposition and defective yeast opsonization. II. Partial purification and preliminary characterization of an opsonic co-factor able to correct sera with the defect.
    Turner MW; Seymour ND; Kazatchkine MD; Mowbray JF
    Clin Exp Immunol; 1985 Nov; 62(2):435-41. PubMed ID: 3910314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of C3b deposition on yeast surfaces by sera of known opsonic potential.
    Turner MW; Mowbray JF; Roberton DR
    Clin Exp Immunol; 1981 Nov; 46(2):412-9. PubMed ID: 7039889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.
    Turner MW; Seymour ND; Kazatchkine MD; Mowbray JF
    Clin Exp Immunol; 1985 Nov; 62(2):427-34. PubMed ID: 2935338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.
    Turner MW; Grant C; Seymour ND; Harvey B; Levinsky RJ
    Immunology; 1986 May; 58(1):111-5. PubMed ID: 3519441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leucocytes.
    Yeaman GR; Kerr MA
    Clin Exp Immunol; 1987 Apr; 68(1):200-8. PubMed ID: 3308208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonization of yeast cells with equine iC3b, C3b, and IgG.
    Gröndahl G; Johannisson A; Jensen-Waern M; Nilsson Ekdahl K
    Vet Immunol Immunopathol; 2001 Aug; 80(3-4):209-23. PubMed ID: 11457475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of opsonins in vacuolar sealing and the ingestion of zymosan by human neutrophils.
    Kemp AS; Turner MW
    Immunology; 1986 Sep; 59(1):69-74. PubMed ID: 3759128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the ingestion mechanisms of IgG and C3b particles in phagocytosis by neutrophils.
    Hed J; Stendahl O
    Immunology; 1982 Apr; 45(4):727-36. PubMed ID: 6279489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of rat complement factor B and its interaction with cell-bound human C3.
    Daha MR; van Es LA
    Immunology; 1980 Dec; 41(4):849-55. PubMed ID: 6906329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
    Naff GB; Hedrick SW; Ratnoff WD; Novak MA; Smith MC; Steiner C; Todd EW
    J Immunol; 1980 Jun; 124(6):2625-31. PubMed ID: 6900053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
    Kerr MA; Falconer JS; Bashey A; Beck JS
    Clin Exp Immunol; 1983 Dec; 54(3):793-800. PubMed ID: 6652976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization.
    Roberton DM; Dhanjal NK; Levinsky RJ; Mowbray JF; Turner MW
    Clin Exp Immunol; 1981 Jan; 43(1):208-14. PubMed ID: 7018758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the serum defect in yeast opsonization in children with fulminant hepatic failure (FHF).
    Larcher VF; Wyke RJ; Mowat AP; Williams R
    Clin Exp Immunol; 1981 Nov; 46(2):406-11. PubMed ID: 7039888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.
    Williams AJ; Hastings MJ; Easmon CS; Cole PJ
    Immunology; 1980 Dec; 41(4):903-11. PubMed ID: 7007217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations.
    Super M; Levinsky RJ; Turner MW
    Clin Exp Immunol; 1990 Feb; 79(2):144-50. PubMed ID: 2311294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial purification and characterization of the high molecular weight latent collagenase from human leukocytes.
    Cohen G; Baici A; Fehr K; Böni A
    Scand J Rheumatol; 1980; 9(1):44-8. PubMed ID: 6246573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and preliminary characterization of aspartate aminotransferase from yeast.
    Cozzani I; Pellegrini M; Barsacchi R; Dibenedetto G; Sgarrella F
    Ital J Biochem; 1974; 23(6):380-92. PubMed ID: 4617747
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial purification of polypeptides activating catalase in Saccharomyces cerevisiae.
    Maqueda M; Valdivia E; Ortega JM; Martinez J; Montoya E
    Microbios; 1986; 46(188-189):179-85. PubMed ID: 3528764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
    Melamed J; Medicus RG; Arnaout MA; Colten HR
    J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.